| abstract |
This invention relates to novel tetralin derivatives having inhibitory activity against an enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase and represented by general formula (I) in which R1 is hydrogen or acetyl, R2 is carboxy and R3 is hydroxy, or R2 and R3 may form lactone, and pharmaceutical acceptable salts thereof, to processes for the preparation thereof and to a pharmaceutical composition comprising the same. |